At 23x forward earnings, with every segment's operating metrics improving, the market is underpricing RTX's near-term operational momentum: aircraft on ground falling, Collins cost actions landing, Raytheon converting a 2.4x book-to-bill.
Read Article ›The market has marked down a franchise for a threat it cannot yet feel, and at 37 times forward earnings Howmet is worth owning — not for a re-rating to $328, but because the business is compounding faster than the multiple needs to expand.
Read Article ›SharkNinja's operating problem this year was making enough product, and the market's residual habit of grouping it with builders and big-ticket retailers understates what the holiday quarter can deliver.
Read Article ›At 16 times forward earnings, this price embeds no margin expansion, no buyback, and a backlog that converts on the market's timetable rather than the contract's.
Read Article ›What kills single-asset biotechs is not usually the science; it is being forced to sell equity into bad news and AbCellera has removed that mechanism for the window in question.
Read Article ›The market is now valuing AppLovin below a diversified mega-cap advertising platform on forward earnings while it grows two to three times as fast, generates over 60% net margins, carries essentially no net debt, and retires stock.
Read Article ›At eleven times forward earnings against a mid-thirties return on equity and a client cohort deepening at 34% per relationship, the risk-reward is skewed to the upside, and the stock is worth owning even after the run.
Read Article ›At roughly 25x next year's consensus earnings for a business converting three-quarters of net income to cash and taking share on both sides of the Atlantic, Eli Lilly is mispriced to the upside — and the risk-reward has not turned, it has merely become less generous than it wa...
Read Article ›What tips the balance is that the approval was not the whole catalyst — it was the start of a data stream that gets richer, not thinner, from here.
Read Article ›The reason the multiple is compressed is not that anyone doubts the ad engine; it is that Meta, alone among the hyperscalers, has no third-party cloud line absorbing the spend.
Read Article ›The Q1 2026 print, the closed Apellis platform, and the explicit 2027 deleveraging path are the evidence that the growth story is no longer unproven — it is showing up in the revenue line and the cash flow. The pipeline readouts in late 2026 and 2027 are real and could break t...
Read Article ›The market has taken the world’s most-owned stock and, inside two months, compressed it to roughly 22–24x consensus NTM / FY27 earnings — not clearly below the S&P 500, but strikingly close to a market multiple for a company whose revenue just grew 85% year over year — on a be...
Read Article ›Coeur Mining has undergone a structural transformation, evolving from a mid-tier silver-and-gold producer into a seven-operation North American precious metals and copper company. The stock trades around $17.70 — roughly 36% below its 52-week high — even as Q1 2026 delivered r...
Read Article ›Summary Natera delivered $697 million in Q1 2026 revenue, beating consensus handily, and crossed 1 million tests processed in a single quarter for the first time. Clinical oncology volumes surged more than 50% year over year, gross margin expanded to 64.7%, and management rais...
Read Article ›Summary RELX shares have fallen roughly 40% from their 52 week high, crushed by a sentiment driven "AI disruption" panic that began when Anthropic launched a legal workflow tool in February. Underneath the sell off, the business is accelerating: 2025 delivered 7% und...
Read Article ›Sunoco LP and SunocoCorp LLC reported strong first quarter 2026 financial and operating results, including a net income of $644 million, adjusted EBITDA of $867 million, excluding one time transaction related expenses, and distributable cash flow, as adjusted, of $535 million....
Read Article ›